H-L-ASP(OCHX)-OH - Names and Identifiers
H-L-ASP(OCHX)-OH - Physico-chemical Properties
Molecular Formula | C10H17NO4
|
Molar Mass | 215.25 |
Density | 1.20±0.1 g/cm3(Predicted) |
Boling Point | 386.2±37.0 °C(Predicted) |
Flash Point | 187.4°C |
Vapor Presure | 4.89E-07mmHg at 25°C |
Appearance | Solid |
pKa | 2.17±0.23(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
Refractive Index | 1.51 |
H-L-ASP(OCHX)-OH - Introduction
L-aspartate 4-cyclohexyl ester, also known as L-Aspartic acid-4-cyclohexyl ester, is an organic compound.
In terms of properties, L-aspartic acid -4-cyclohexyl ester is a colorless liquid with a special molecular structure of amino acids. It has good solubility and is soluble in most organic solvents, such as methanol and ethanol.
In terms of uses, L-aspartate-4-cyclohexyl ester is used as a potential anticancer drug in the medical field. It has anti-tumor activity and can fight malignant tumors by increasing the body's immune function. In addition, it is also used as a chemical reagent and plays an important role in organic synthesis.
In terms of preparation method, L-aspartic acid -4-cyclohexyl ester can be obtained by esterification reaction of aspartic acid and cyclohexanoic acid ester. Specific synthetic methods can refer to organic chemical synthesis textbooks or related literature.
In terms of safety information, there are currently limited data on the toxicity and safety of 4-cyclohexyl L-aspartate. In addition to general precautions for chemical substances, use should follow laboratory safety procedures and wear appropriate personal protective equipment when synthesizing or using. In addition, if the compound is intended for medicinal use, it should be used in accordance with relevant regulations and guidelines and under professional guidance. The safety assessment and management of chemical reagents should be carried out according to the specific purpose and situation. In all cases, safety should be the primary consideration and follow relevant regulations and guidance.
Last Update:2024-04-10 22:30:50